Bispecific antibodies in cancer therapy. | Curr Opin Immunol;11(5): 558-62, 1999 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Bispecific antibodies in cancer therapy.

Segal, D M; Weiner, G J; Weiner, L M.

Affiliation

Segal DM; Immune Targeting Section, Experimental Immunology Branch, National Cancer Institute, Building 10 Room 4B36, National Institutes of Health, Bethesda, MD 20892-1360, USA. dave_segal@nih.gov

Curr Opin Immunol ; 11(5): 558-62, 1999 Oct.

Article in En | MEDLINE | ID: mdl-10508714

Subject(s)

Antibodies, Bispecific/therapeutic use; Neoplasms/therapy; Antibodies, Bispecific/toxicity; Clinical Trials as Topic; Drug Design; Humans; Recombinant Proteins/therapeutic use

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Neoplasms Limits: Humans Language: En Journal: Curr Opin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 1999 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Neoplasms Limits: Humans Language: En Journal: Curr Opin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 1999 Document type: Article Affiliation country: United States Country of publication: United kingdom